Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PD-L1 antibody (Center)

This Rabbit Polyclonal antibody specifically detects PD-L1 in WB, IF and IHC (p). It exhibits reactivity toward Human, Mouse and Ratand has been mentioned in 1 publication.
Catalog No. ABIN500467

Quick Overview for PD-L1 antibody (Center) (ABIN500467)

Target

See all PD-L1 Antibodies
PD-L1 (CD274 (PD-L1))

Reactivity

  • 211
  • 139
  • 65
  • 6
  • 6
  • 5
  • 5
  • 1
  • 1
Human, Mouse, Rat

Host

  • 136
  • 91
  • 20
  • 5
  • 4
  • 4
  • 2
  • 1
Rabbit

Clonality

  • 138
  • 116
  • 7
Polyclonal

Conjugate

  • 115
  • 21
  • 15
  • 14
  • 10
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This PD-L1 antibody is un-conjugated

Application

  • 166
  • 136
  • 66
  • 63
  • 40
  • 34
  • 28
  • 22
  • 22
  • 14
  • 11
  • 9
  • 7
  • 7
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Binding Specificity

    • 31
    • 29
    • 16
    • 15
    • 10
    • 9
    • 7
    • 7
    • 7
    • 6
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Center

    Specificity

    This antibody detects CD274 / PDL1. It is specific to the larger isoform. PDL-1 antibody has no cross-reactivity to PDL-2.

    Cross-Reactivity (Details)

    Species reactivity (tested):Human, Mouse, Rat.

    Purification

    Peptide affinity chromatography

    Immunogen

    PDL-1 antibody was raised against a 17 amino acid peptide from near the center of human PDL-1.

    Isotype

    IgG
  • Application Notes

    ELISA. Western blot: 0.5 - 1 μg/mL. Immunohistochemistry on paraffin sections.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Buffer

    PBS, 0.02 % Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Avoid repeated freezing and thawing.

    Storage

    4 °C/-20 °C

    Storage Comment

    Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
  • Chentoufi, Kritzer, Tran, Dasgupta, Lim, Yu, Afifi, Jiang, Carpenter, Osorio, Hsiang, Nesburn, Wechsler, BenMohamed: "The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanism." in: Journal of virology, Vol. 85, Issue 17, pp. 9127-38, (2011) (PubMed).

  • Target

    PD-L1 (CD274 (PD-L1))

    Alternative Name

    CD274 / PDL1

    Background

    Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. PDL-1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells. This suggests that PDL-1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts. At least two isoforms of PDL-1 are known to exist.Synonyms: B7 homolog 1, B7H1, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, Programmed cell death 1 ligand 1, Programmed death ligand 1

    Gene ID

    29126

    NCBI Accession

    NP_054862

    UniProt

    Q9NZQ7

    Pathways

    Cancer Immune Checkpoints
You are here:
Chat with us!